TrialCancer medicine2014
A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer.
Sara M Tolaney et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled ittrialcites it